BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lannett Company, Inc. 

9000 State road

Philadelphia  Pennsylvania  19136  U.S.A.
Phone: 800-325-9994 Fax: 215-333-9004


SEARCH JOBS




Industry
Suppliers






 Company News
Lannett Company, Inc. (LCI) Names Michael Bogda As President 12/5/2014 8:34:31 AM
Lannett Company, Inc. (LCI) To Present At The Oppenheimer 25th Annual Healthcare Conference On December 10 12/2/2014 2:59:07 PM
Lannett Company, Inc. (LCI) Announces Retirement Of Executive Officer 11/18/2014 12:59:01 PM
Lannett Company, Inc. (LCI) Reports Net Sales Of $93 Million, EPS Of $0.94 For Fiscal 2015 First Quarter 11/4/2014 10:17:45 AM
Lannett Company, Inc. (LCI) Announces Positive FDA Inspection Results 11/3/2014 12:01:24 PM
Lannett Company, Inc. (LCI) Receives FDA Approval For Letrozole Tablets USP 2.5 mg 10/30/2014 10:13:40 AM
Lannett Company, Inc. (LCI) To Present At The 2014 Credit-Suisse Healthcare Conference On November 11 10/29/2014 9:23:17 AM
Lannett Company, Inc. (LCI) Announces Preliminary Fiscal 2015 First Quarter Net Sales Of Approximately $93 Million, EPS Between $0.91 And $0.94 10/23/2014 11:57:32 AM
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014 10:54:21 AM
Lannett Company, Inc. (LCI) Receives FDA Approval For Oxycodone Hydrochloride Oral Solution USP, 100 mg Per 5 mL 9/11/2014 10:53:06 AM
12345678910...